olone may be related to inhibition of granulocyte accumulation in the lung. In addition, this study provides further evidence that the two phases of the reaction are pathogenically separable. Inherited forms of lactic acidosis have been recognized since the early 1960s (7, 12, 17) . Recently, these disorders have been classified into errors of the gluconeogenic or oxidative pathways leading from pyruvate.
Inherited forms of lactic acidosis have been recognized since the early 1960s (7, 12, 17) . Recently, these disorders have been classified into errors of the gluconeogenic or oxidative pathways leading from pyruvate.
In the gluconeogenic group, lactic acidosis is accompanied by hypoglycemia and is exacerbated by fasting. The most frequent cause is deficiency of pyruvate carboxylase (EC 6.4.1. l), an intramitochondrial enzyme which can be measured in fibroblasts (1, 20) and amniocytes (9, 1 1) making antenatal diagnosis possible. In isolated pyruvate carboxylase deficiency, therapy has generally been unsatisfactory (13, 27) and prognosis is poor. When other carboxylases are affected, the disorder involves attachment of biotin to the apocarboxylase or biotin availability and may be successfully treated by pharmacologic doses of this cofactor (22, 25) . Phosphoenolpyruvate carboxykinase (EC 4.1.1.32) may be measured in fibroblasts, but deficiencies of this enzyme associated with lactic acidosis are rare (l4,21). Fructose-1,6-diphosphatase (EC 3.1.3.1 1) and glucose-6-phosphatase (EC 3.1.3.9) deficiencies are diagnosed in gluconeogenic tissues and may be managed by frequent carbohydrate feeds (2, 15, 16) .
Errors of the oxidative pathway of pyruvate metabolism are less amenable to therapy. Patients with abnormal enzymes of the pyruvate dehydrogenase complex have been treated with dichloroacetic acid (an activator of the first component), thiamine (a cofactor for the first component), lipoic acid (a cofactor for the second component), and ketogenic diets (to provide ketone bodies as an alternative energy substrate for cerebral metabolism). Blood lactate levels may be reduced, but psychomotor retardation has not been improved (3, 8, 28) . There are reports of lactic acidosis in association with defects in the electron transport chain (6, 26, 29) , but these cases are incompletely understood and were unresponsive to therapy. The patients exhibited a subacute myopathy with morphologic abnormalities of muscle mitochondria.
In the late 1960s, attempts were made to treat toxin-induced lactic acidosis with the redox dye, methylene blue. Some improvement was achieved for phenformin toxicity (1 9), but this is not a recognized therapy for the hereditary forms of lactic acidosis. In this report, we discuss the effects of methylene blue on defective lactate oxidation by fibroblasts from a patient with an inherited form of lactic acidosis.
CASE HISTORY
The proband was born at 4 1 weeks without complication. She was small for gestational age (body weight, 2 180 g) and fed poorly during the first week of life. On day 7, she was noted to have mild metabolic acidosis and was transferred to The Montreal Children's Hospital. At that time, she was tachypneic, irritable, and hypertonic and exhibited scissoring of the lower extremities. There were no dysmorphic features, but the liver was enlarged. Initial laboratory data included: blood pH of 7.4, C02 tension of 22 mm Hg, bicarbonate of 14.2 mEq/liter and an anion gap of 30 mEq/liter.
Oral feeds were discontinued and acidosis was corrected with intravenous bicarbonate. Mild hypoglycemia (34 mg/dl) was corrected with a 15% dextrose infusion. During this period, serum amino and organic acids were measured (see Table 1 ) and were suggestive of a primary lactic acidosis. Urinary amino and organic acids were unremarkable except for massive elevation of lactate, a-and 0-hydroxybutyrates, and a modest elevation of alanine. On the 15th day of life, oral feeds of Similac-20 were begun. Within 36 h, worsening acidosis and seizures were followed by cardiac arrest and death.
Parents were nonconsanguinous. A previous male sibling died of lactic acidosis on the 8th day of life. A subsequent female sibling is asymptomatic.
MATERIALS AND METHODS
Control cell strains were obtained from the Repository for Mutant Human Cells at the Montreal Children's Hospital Research Institute. Cultured skin fibroblasts from the proband and subsequently from the parents and a younger sibling were established from primary cultures of full thickness punch biopsies. (23) without glucose with the appropriate isotope at 37" C (total volume, 2.0 ml) for 90 min. Reactions were stopped by the addition of 9 N sulfuric acid (50 p1) and the I4CO2 was trapped on filter papers containing 50 p1 of 1 N potassium hydroxide. Prior to scintillation counting in Formula 963 (New England Nuclear), 0.25 ml of water was added to the KOH paper. Pyruvate dehydrogenase was assayed on cell sonicates by the method of Stromme (24) . Measurement of lactate and other organic acids was by gas-liquid chromatography-mass spectroscopy; amino acids were measured by automated amino acid analysis (Dionex).
RESULTS
Difficulty was encountered in establishing cultures from the proband. The medium became very acidic due to a build-up of lactate levels in excess of 11 mM (normal value for cells grown under the same conditions was less than 3.5 mM). Cells growing from the explant tended to peel from the plastic Petri dishes when confluent; this same phenomenon occurred when the cells were cultured in 75-cm2 plastic flasks. With more frequent feedings and a larger volume of medium, the cells grew normally.
The proband's fibroblasts exhibited a marked inability to decarboxylate L-[l-'4C]lactate (1 mM); activity was consistently below 10% of the lowest control value (Table 2) . Fibroblasts from both parents and an unaffected sibling gave normal values for the production of carbon dioxide from L-lactate.
There was considerable interstrain variation in lactate metabolism by normal fibroblasts, but low variation within individual strains. The variation was not related to age (1 month-35 years), sex of donor, or the number of doublings in culture (at least up to 30 doublings).
Defective lactate metabolism could not be attributed to defi- ciency of lactate dehydrogenase activity since pyruvate (1 mM) decarboxylation by the proband's fibroblasts was undetectable and alanine (I mM) conversion to carbon dioxide was similarly depressed, i.e. 13% of controls (see Table 3 ). All of these substrates enter pathways of oxidative metabolism in the form of pyruvate. On the other hand, substrates which enter the tricarboxylic acid cycle without being converted to pyruvate (e.g. [2,3- 14C]succinate and L-[U-I4C]aspartate) were oxidized to I4CO2 at normal rates by the proband's fibroblasts (Table 3) .
Oxidation of pyruvate requires entry of this substrate into the mitochondrion and decarboxylation via the multienzyme complex, PDH. PDH regulation is accomplished by a process of activation-deactivation involving phosphorylation of the first component. The kinase which inactivates PDH can be inhibited by dichloroacetic acid (5) . When the patient's fibroblasts were exposed to dichloroacetic acid (0.5 mM), a slight stimulation (200% of basal value) of lactate oxidation was noted but activity remained far below the lower limit of control.
Assay of PDH activity of the proband's fibroblasts showed near-normal activity [19.5 k 3.1 (SEM) nmol COdmg protein/ h or 82 + 9% of three control strains]. However, this in vitro assay is performed at saturating concentrations of cofactors and may not reflect activity in the intact cell. To test the possibility that in vivo PDH activity was deficient in the proband due to an abnormality of cofactor availability, we examined fibroblast utilization of other substrates which are oxidized via separate multienzyme dehydrogenases, i.e. glutamate and leucine. As can be seen from Table 3 , decarboxylation of these substrates was markedly reduced.
Several attempts were made to correct lactate oxidation in intact fibroblasts by supplementing the cells with cofactors involved in the multi-enzyme dehydrogenases. Table 4 shows that thiamine supplementation made no difference to the ability of proband cells to oxidize lactate to C02 ( p < 0.05).
Lipoic acid supplementation. The second component of the PDH complex, lipoate acetyltransferase (EC 2.3.1.12), is a lipoic Table 3 .
Conversion of various sub5
Substrate Proband acid-dependent enzyme which transfers the two-carbon unit derived from pyruvate to coenzyme A. Fibroblasts from the proband and control were treated at confluence for 18 h with lipoic acid (0.1 mM) added to the culture medium; no improvement of lactate oxidation was noted (Table 4) .
Electron acceptor supplementation. The third component of the PDH complex, lipoamide dehydrogenase (EC 1.6.4.3), is required to reoxidize the lipoic acid of lipoate acetyltransferase. Oxidizing equivalents derived from the electron transport chain are linked to this step via redox reactions involving FAD and NAD. To test for a possible defect in electron transfer in the proband's cells, incubation medium was supplemented with a variety of electron acceptors (methylene blue, nitroblue tetrazolium, dichlorophenolindophenol, and potassium ferricyanide) during substrate oxidation assays. Although nitroblue tetrazolium and potassium femcyanide had no effect on the patient's cells, methylene blue (25 pg/ml) and dichlorophenolindophenol (25 pg/ml) produced dramatic repair of lactate oxidation (12 to 13-fold stimulation above basal values). Methylene blue was chosen for further studies since it has been used clinically (10) . Figure 1 shows that the addition of methylene blue increased conversion of L-[l-14C]lactate to I4CO2 by the proband's cells, but had no significant effect on activity of control fibroblasts. Methylene blue did not produce spontaneous decarboxylation of lactate in the absence of cells, nor did it stimulate the deficient lactate oxidation in a fibroblast strain derived from a patient with documented pyruvate decarboxylase deficiency. Alanine oxidation to C02 by the proband's cells was similarly increased (14-fold) upon addition of methylene blue. Under the same conditions, alanine oxidation by control cells was significantly inhibited. Oxidation of leucine and glutamate was deficient in the proband's cells; modest improvement was noted in the presence of methylene blue (4-fold and Zfold, respectively).
DISCUSSION
In this report, we describe a case of inherited lethal lactic acidosis presenting in the newborn period. The pattern of inheritance appears to be autosomal recessive since the proband was female and an older male sibling died in the newborn period with persistent elevated blood lactate. The nonconsanguinous parents were clinically unaffected, and their fibroblasts converted lactate to carbon dioxide in the low normal range. Considering
Ytrates to I4CO2 by intactfibroblasts* the wide range of normal activity and the distance of the assay from the primary gene defect, this may represent the heterozygous state.
In a series of 40 cases, Robinson et al. (2 1) were able to identify metabolic abnormalities in fibroblasts derived from 14; their studies usually involved direct measurement of enzyme activity in cell extracts. The metabolic basis of lactic acidosis in our patient could not be diagnosed from clinical parameters, but her intact fibroblasts clearly expressed the defect, causing lactate accumulation and consequent acidification of the growth medium. This observation and initial studies demonstrating defective conversion of lactate, pyruvate, and alanine to carbon dioxide suggested an error in oxidative metabolism of pyruvate. Fibroblasts from patients with primary gluconeogenic disorders convert lactate to carbon dioxide at normal rates (e.g. the strain with pyruvate carboxylase deficiency cited in Table 2 ).
When the proband's fibroblasts were challenged with substrates such as aspartate and succinate, which enter the tricarboxylic acid cycle independent of multienzyme dehydrogenase complexes, activity was normal. This finding indicated that the disorder of pyruvate was not an artifact of dying cells.
Activity of the PDH complex was measured in fibroblast extracts from the proband. The modest reduction in activity compared to control strains could not explain the severely deficient utilization of pyruvate by intact cells. To test the hypothesis that cofactor availability was abnormal and rate-limiting in intact fibroblasts, we attempted to correct lactate oxidation by supplementing the cells with high levels of relevant cofactors. Although thiamine and lipoate were without effect, addition of certain artificial electron acceptors (methylene blue and dichlorophenolindophenol) produced dramatic correction of lactate oxidation to levels approaching the lower limits of normal. Methylene blue had a specific effect on the proband's cells and did not augment lactate or alanine conversion to carbon dioxide in normal or PDH-deficient fibroblasts.
As can be seen by Figure 1 , conversion of glutamate and leucine were deficient in the proband's cells, and significant stimulation was achieved by methylene blue supplementation. Branched chain amino acids were modestly elevated in the patient's serum (Table 1) ; this sample was drawn during the initial hospital course with high glucose (1 5% glucose-containing intravenous solution), zero protein intake. At these levels of branched chain amino acids, an elevation of the corresponding ketoacids would not be expected in either serum or urine (18) .
To explain the effect of methylene blue on the proband's fibroblasts, we hypothesized that coupling of lipoamide dehydrogenases to the electron transport chain or intramitochondrial electron acceptor availability was abnormal, resulting in an accumulation of reduced pyridine dinucleotides. Such an abnormality in cellular redox state would explain the abnormally high lactate to pyruvate and P-hydroxybutyrate to acetoacetate ratios observed in the patient's serum. Furthermore, intramitochondrial accumulation of reduced pyridine dinucleotides would explain: 1) the defect in flux of pyruvate through PDH observed in the intact cell, but not in the cell sonicate; and 2) the deficient whole-cell oxidation of glutamate and leucine, substrates which utilize similar lipoamide dehydrogenase-containing multienzyme complexes.
Inherited forms of lactic acidosis presenting in the neonatal period are usually lethal within a few weeks of onset, leaving little time for enzymic diagnosis. Therefore, affected infants are often challenged with a series of potentially therapeutic drugs based on reports of correctable metabolic errors (such as biotinresponsive forms of multiple carboxylase deficiency). Although hemolysis has been reported with use of methylene blue in certain clinical situations (4), it has been successfully employed in long term oral therapy of inherited methemoglobinemia (10) . In view of its beneficial in vitro effects in our case, we propose that methylene blue be included among the trial therapies for newborns with life-threatening congenital lactic acidosis.
production of OF for all infants studied. This discrepancy might be related to abnormal release or diminished cell content of a cofactor necessary for production of 'OH from 0;. Since both lactoferrin (LF) found in specific granules and myeloperoxidase (MPO) found in azurophilic granules have been shown to enhance 'OH generation, we compared degradation of both granule types in response to PMA and opsonized zymosan and total neutrophil content of MPO, LF, and lysozyme in cord blood and adult neutrophils. Degranulation, even after pretreatment with cytochalasin B, was the same for newborn and adult neutrophils. Content of MPO was identical (adult, 204 f 24 A units, mean f SEM, n = 9; newborn, 201 f 21, n = 9) but lysozyme was mildly diminished (adults, 111 f 10 A units;
